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Abstract
Background: The Diabetes Manual is a type 2 diabetes self-management programme based upon
the clinically effective 'Heart Manual'. The 12 week programme is a complex intervention
theoretically underpinned by self-efficacy theory. It is a one to one intervention meeting United
Kingdom requirements for structured diabetes-education and is delivered within routine primary
care.
Methods/design: In a two-group cluster randomized controlled trial, GP practices are allocated
by computer minimisation to an intervention group or a six-month deferred intervention group.
We aim to recruit 250 participants from 50 practices across central England. Eligibility criteria are
adults able to undertake the programme with type 2 diabetes, not taking insulin, with HbA1c over
8% (first 12 months) and following an agreed protocol change over 7% (months 13 to 18). Following
randomisation, intervention nurses receive two-day training and delivered the Diabetes Manual
programme to participants. Deferred intervention nurses receive the training following six-month
follow-up. Primary outcome is HbA1c with total and HDL cholesterol; blood pressure, body mass
index; self-efficacy and quality of life as additional outcomes. Primary analysis is between-group
HbA1c differences at 6 months powered to give 80% power to detect a difference in HbA1c of
0.6%. A 12 month cohort analysis will assess maintenance of effect and assess relationship between
self-efficacy and outcomes, and a qualitative study is running alongside.
Discussion: This trial incorporates educational and psychological diabetes interventions into a
single programme and assesses both clinical and psychosocial outcomes. The trial will increase our
understanding of intervention transferability between conditions, those diabetes related health
behaviours that are more or less susceptible to change through efficacy enhancing mechanisms and
how this impacts on clinical outcomes.
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International health policy
The past decade has seen an international trend towards
providing primary care based diabetes services with
patient education and self-management at the forefront.
The International Diabetes Foundation (IDF)[1] stand-
ards advocate that "implementation of diabetes education
is learner-centred, facilitates cognitive learning, behaviour
change and self-management". These are challenging
goals for health care providers to uphold but nonetheless
are being incorporated into national health policies. For
example, shared decision making is a standard promoted
in Finland [2], the Americas [3] and the Netherlands [4].
In the United Kingdom (UK), health professionals are
expected to work with people living with diabetes to
develop their confidence, skills and knowledge, engage in
shared decision making and to provide theory-based
structured education [5-7]. It has been proposed that such
education should meet four criteria [8]: (i) have a struc-
tured, written curriculum (ii) have trained educators (iii)
be quality assured, and (iv) be audited. The majority of
people living with type 2 diabetes access education, infor-
mation and support through primary care [9] which is
currently structured, almost exclusively, around individ-
ual patient consultations. The potential of practice nurses
to support individuals in structured patient self-manage-
ment education within this existing, and valued, primary
care structure needs to be built upon.
Self-management interventions improve clinical outcomes
Psychological interventions for use in type 2 diabetes have
been systematically reviewed and pooled trial results sug-
gest they reduce HbA1c by a clinically significant 1% [10].
The need for research that combines psychological inter-
ventions with educational packages to understand the
impact of psychological interventions on self-manage-
ment behaviours has been recognised [11]. Hampson et al
[12] reviewed behavioural interventions for adolescents
with type 1 diabetes and found that only a minority of
studies described interventions that were explicitly based
on theories. The theoretically determined interventions,
however, generated larger effect sizes than those that were
atheoretical. Earlier systematic reviews of patient self-
management training in long term conditions [13-15]
concluded that collaborative self-management interven-
tions, where people respond to clinical information and
goal setting, represent the most effective self-management
approaches for improving clinical outcomes. Together,
these reviews suggest a need to explore theory-based self-
management intervention development, involving bio-
medical feedback and goal evaluation.
Self-efficacy theory
Improving an individual's self-efficacy is particularly
important in long term disease self-management as it
reflects capacity to carry out health related behaviours that
are likely to improve outcome[16]. This parameter is
based on social learning theory and reflects an individ-
ual's level of confidence in their ability to perform partic-
ular behaviours. Interventions to increase efficacy based
on this theory, include four specific techniques of facilitat-
ing personal mastery, vicarious (observing others) learn-
ing, identifying distress and providing verbal persuasion.
These have been shown to be powerful ways for people to
learn new behaviours and activities. Enhancing self-effi-
cacy in long term disease management has been shown to
be associated with lower levels of health care consump-
tion and improved psychosocial adjustment [17, 18, 19,
20].
One to one education
The evidence for the effectiveness of group education is
growing, [7,21] but group approaches do not suit every-
one [22]. Randomised controlled trials of the Heart Man-
ual [23,24], a home-based one-to-one secondary
prevention programme for coronary heart disease, dem-
onstrated findings that were at least equal to group
approaches. Dalal & Evans [22] reported that the one to
one Heart Manual was 11% more popular with primary
care patients than the group alternative. It also had an
87% programme completion rate compared to the 33%
completion rate of the group-based programme. The
study found those over 60 years, the self-employed and
those living in rural locations to particularly prefer an
individual approach. Individual approaches and group-
based self-management programmes may, therefore, be
complementary. Both may be needed to engage the wide
constituency of people requiring diabetes self-manage-
ment education.
The Diabetes Manual intervention
The Diabetes Manual, combining the three preceding
strategies for improving outcomes in a single package, was
developed at the University of Warwick in 2003–4, based
on the Heart Manual. The development of a programme
was prioritised in a needs assessment [25] and its subse-
quent development was informed by both lay and profes-
sional expert panels. Two focus groups of people with type
2 diabetes confirmed that the penultimate draft of the
Diabetes Manual had face validity. The Diabetes Manual
programme incorporates self-efficacy enhancing text and
activities and has been designed to enable patients to gain
confidence and skills quickly and progressively in the
management of their diabetes[26]. The programme has
five components, i) two-day training for nurse to deliver
the programme ii) 12 week patient manual iii) relaxation
audiotape iv) frequently asked questions audiotape forPage 2 of 8
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weeks 1,5 and 11. The Diabetes Manual is designed to be
offered to patients during primary care consultations with
GPs and practice nurses and therefore is intended to have
high availability to its target population. It is able to meet
the UK standards for structured education in diabetes [8].
This paper discusses a trial that is now underway to test
the effectiveness of the Diabetes Manual programme.
Trial objectives
Primary objective
To determine the efficacy of the Diabetes Manual in type
2 diabetes for improving glycaemic control at 6-months
compared with usual care and to determine the persist-
ence of effect at 12 month in the intervention group.
Secondary objectives
To determine the efficacy of the Diabetes Manual in mod-
ifying the following risk factors for cardiovascular disease:
total serum cholesterol; HDL cholesterol; blood pressure
and BMI. To reduce anxiety and improve quality of life
and self-efficacy.
Methods/design
The Diabetes Manual trial is a two-arm RCT, clustered by
GP practice with an intervention arm and a control arm in
which intervention is deferred and delivered at six-
months. As the practice nurse is the target of the educa-
tional intervention, the design appropriately takes the
practice as the unit of randomisation. The trial is being
managed by the Centre for Primary Health Care Studies,
University of Warwick, UK. Ethical approval was granted
by the Northern and Yorkshire Multi-centre Research Eth-
ics Committee in June 2004.
Practices and participants
GP practices from three Strategic Health Authorities in
central England have been recruited. Practice eligibility is
i) employment of a practice nurse who has undertaken
post-registration diabetes care training and ii) use of a lab-
oratory in which HbA1c ranges and assays are DCCT
aligned [27] determined and stable. Patient eligibility cri-
teria are adults with type 2 diabetes, not taking insulin
and able to read and write English. During the first 12
months of the study, eligible patients had a most recent
HbA1c over 8%. We experienced low recruitment over this
period as trial commencement concurred with the imple-
mentation of a payment linked quality improvement pol-
icy [28] during which time GPs have become more
aggressive in the prescribing of oral hypoglycemic agents
and insulin in an attempt to reduce each patient's HbA1c
to below the maximum payment threshold of 7.4%. This
has resulted in considerably fewer patients than antici-
pated meeting the eligibility criteria. It also means that eli-
gible patients include a greater proportion of those for
whom more aggressive pharmacological management
was not working either due to poor attendance at reviews,
complex diabetes management situations or treatment
concordance issues. One year into the trial a protocol
change was agreed by the investigators, funders and the
research ethical committee to enhance patient recruit-
ment by reducing the patient eligibility to a minimum of
HbA1c 7%.
Screening eligibility
Participating practices identified eligible patients from
practice registers and a researcher visited to collect aggre-
gated data for all eligible patients and generate a random
ordered recruitment list [figure 1]. Aggregated, ano-
nymised HbA1c, blood pressure (BP), body mass index
(BMI) and basic demographic data of the eligible practice
populations were collected prior to recruitment to allow
any difference between the actual study participants and
the eligible population to be identified. Patients were
invited to participate by the nurse according to the ran-
dom order list. This ensured that patients were invited
consecutively on the grounds of eligibility rather than on
the grounds of anticipated concordance by the practice
nurse. The list was followed until 12 patients were
recruited or the list was exhausted. All patients were
recruited prior to practice cluster randomisation.
Baseline assessment
Baseline clinical assessment was conducted by the practice
nurse prior to randomisation during an additional diabe-
tes review. Blood samples for HbA1c assessment, total and
HDL cholesterol were taken by the nurse and analysed
outside the practice by the DCCT aligned [27] laboratory
blinded to practice or patient group allocation. A self-
completion booklet of questionnaires consisting of
demographic questions, the problem areas in diabetes
scale (PAID) [29], the diabetes management self-efficacy
scale (DMSES) [30] and the diabetes self-care activities
measure [31] was given to the patient by the nurse at base-
line for return in replied paid envelope to the research
team. Process data consisted of the diabetes self-care activ-
ities scale [31] and prescribed medication collected by the
practice nurse during clinical assessment. Demographic
data includes age, gender, net weekly income, highest
educational qualification, ethnicity and duration of dia-
betes.
Outcome assessment
Follow up for all measures is at six months post randomi-
sation for both arms and 12 months post randomisation
for the intervention arm to assess maintenance of effect
on all measures. Six and 12-month clinical assessment is
carried out by the practice nurse during a diabetes review.
Psychosocial measures are collected by self-completion
patient postal questionnaire.Page 3 of 8
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Following patient baseline data collection, practices were
minimised [32] into intervention and control arms
according to mean HbA1c of recruited patients, practice
self-assessed quality of diabetes care indicators [28] and
the number of individuals recruited [figure 2]. Computer-
aided minimisation was undertaken by a statistician blind
to practice identity. All members of the research team who
will be inputting, analysing and interpreting both qualita-
tive and quantitative data are blind to the group alloca-
tion of practices and participants. The nurse trainer, one
research fellow and one secretary remain unblinded to
ensure effective communication and support between the
research team, the practices and the participants regarding
training events and follow-up data collection.
The interventions
The intervention arm practice nurses undertake a two-day
training in facilitation skills associated with use of the
Diabetes Manual, including practical skill development
and underlying theoretical principles of self-efficacy [see
Additional file 1]. The nurse training syllabus incorpo-
rates efficacy enhancing mechanisms and therefore pro-
vides an experiential model for the nurses. Recruited
patients have a 20 minute consultation with the trained
nurse to introduce the 12-week Diabetes Manual pro-
gramme. The first two patients that each nurse delivers the
intervention to are intended to be practise consultations
with ineligible patients to ensure she has gained familiar-
ity with the intervention delivery procedures. The control
arm receives usual care for a period of six months. Follow-
ing six-month data collection, control arm nurses receive
the training and deliver the Diabetes Manual to the
recruited patients in their practice. No further trial data is
collected from control arm participants thereafter.
Trial management
A trial steering group has been formed consisting of the
full research team, the nurse trainer, a practice nurse and
two lay people from the Warwick Diabetes Care Research
User Group. Due to the low risk nature of the interven-
tions, a data monitoring committee is not necessary.
Flowchart of trial from recruitment to randomisationigure 1
Flowchart of trial from recruitment to randomisation.
Consent 
• Practice visit by researcher 
• Eligible patients identified by nurse 
• Anonymised aggregated data of all eligible patients collected
• Random order list of eligible patients generated  
• Patients invited to participate according to random order list 
20-min practice nurse-patient consultation to  
• Discuss raised Hb1Ac and implications for developing complications 
• Take informed consent 
• Collect baseline measures 
• Patient informed that Diabetes Manual appointments will follow once 
randomisation has occurred 
Block allocation of practices (clusters) to intervention or deferred 
intervention groups using minimisation.
Send invitation to next ten patients 
on the eligibility list until either 12 
patients have consented or all 
eligible patients have been invited
No consent Page 4 of 8
(page number not for citation purposes)
BMC Family Practice 2006, 7:45 http://www.biomedcentral.com/1471-2296/7/45Quality assurance
Standardised delivery of the interventions will be assured
by i) the nurse training programme being accompanied
by detailed written material to which the nurses can refer
during the intervention delivery; ii) analysis of a tele-
phone support data sheet used by the nurses to prompt
and record telephone discussion; iii) the nurse audio
records 1 in 6 telephone support calls and the teaching
and research team listen to half of these calls, and assesses
them against the training protocol for telephone support
and iv) 12 patients in each arm will be invited to partici-
pate in a semi-structured interview, and this data will be
Trial flowchart from randomisation to completion at 12 month follow-upFigure 2
Trial flowchart from randomisation to completion at 12 month follow-up.
Practices randomised (minimised) in blocks to intervention or 
deferred intervention groups 
Intervention Group
• Nurses receive training 
• Deliver Diabetes Manual to 
participants  
12 month follow-up
• 11 months-Postal questionnaire 
sent to home and returned to 
researchers 
• 12-months Clinical data 
collected by nurses 
Deferred intervention Group
• Participants informed by nurse that 
they will contact them again about 
the Diabetes Manual once they 
have received training 
• Resume usual care pattern 
6-month follow-up
• 5 months-Postal questionnaire 
sent to home and returned to 
researchers 
• Interviews conducted with sample
• Clinical data collected by nurse 
6-month follow-up
• 5 months-Postal questionnaire 
sent to home and returned to 
researchers 
• Interviews conducted with sample
• Nurse undergoes training 
• Clinical data collected by nurse 
and Diabetes Manual programme 
delivered to participants 
• No further data collection from 
this arm Page 5 of 8
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nurses for a selection of the patients and programme
adherence by the patients.
Qualitative Study
Patient interviews
Twelve semi-structured interviews are being undertaken
with a purposive sample from each arm of the trial (n =
24). Sampling aims to capture differing self-efficacy levels
and educational attainment and practice location. The
interviews will explore any differences in the intervention
and control arm experience of diabetes management dur-
ing the trial period. The interviews are completed during a
two-week period following completion of the six-month
questionnaire data and before the collection of follow-up
clinical data so that the interview does not influence the
questionnaire completion. The interviews' close proxim-
ity to the clinical follow-up review will limit its influence
on clinical outcomes such as HbA1c.
Health professionals' views
Two focus groups will be held following six-month data
collection for trained, intervention arm, practice nurses to
capture their perspective of the Diabetes Manual pro-
gramme.
Sample size and rate of recruitment
We originally sought power of 90% (alpha = 0.05) to
detect a 0.6% difference in individual patient HbA1c
between intervention and control arms. Based on feasibil-
ity work, we estimated that the number of patients who
have type 2 diabetes per recruited practice that meet the
inclusion criteria would be an average of 80 so it would be
reasonable for each practice to recruit and manage
between 5–12 patients (expected mean number of
patients = 10). Using an intra cluster correlation for
HbA1c of 0.043 and allowing for 15% patient attrition
and variability in clusters size gives an adjusted sample
size of 212 in each arm. Allowing for an attrition rate of
10% for practices, we aimed to recruit a total of 46 prac-
tices, each willing to recruit up to12 patients. Because of
the lower rate of patient recruitment in the first twelve
months, we expected fewer patients per practice. We com-
pensated for this by recruiting more practices. We esti-
mated that with analysable data on five patients per
practice in 50 practices the power of our study to detect a
0.6% difference would be 80% (accounting for between
cluster correlation and variable cluster size as described
above). This gives a lower power than we originally aimed
for but was a realistic target.
Statistical analysis
Data is double entered and discrepancy checks carried out
with source data. To account for clustering by practice, pri-
mary and secondary outcomes will be analysed using pop-
ulation averaged models with robust standard errors
(using generalised estimating equations). Patient and
practice level covariates thought to be related to outcome,
including practice self-assessed quality of diabetes care
indicators [28], geographical location of practice, level of
patient outcome at baseline (where available), and
patient age, gender, education and socio-economic status
will be considered for incorporation in the analysis. Cov-
ariates will be included if they show a strong (α<10%)
relationship with outcome. We will also include a covari-
ate representing whether the practice was recruited before
or after the change in protocol relating to HbA1c levels. To
detect the presence of any significant differences in effect
between sub-groups, we will fit first order interaction
terms for interactions between intervention and the fol-
lowing factors which represent the sub-groups of interest:
laboratory used for blood sample analysis, patient age and
educational attainment. Separate models will also be fit-
ted for the separate subgroups, but these results will be
exploratory rather than definitive. The questions we aim
to explore in the subgroup analyses are: Is the effect on
HbA1c different for patients recruited before and after the
protocol change or for patients in different age groups? Is
any effect on self-efficacy different for older and younger
patients or by educational attainment?
Discussion
This trial aims to evaluate the efficacy of an intervention
that offers structured diabetes education and theoretically
informed self-management skills training. This delivery of
both educational and psychological components in a sin-
gle programme offers the potential for people to learn
about their diabetes in a psychologically motivating and
confidence enhancing structure. The systematic reviews of
both Hampson et al [12] and Ismail et al [10] indicate the
need to develop and evaluate these combined approaches
to ensure that treatment concordance between patients
and health professionals can be achieved. Within our
intervention the patient is encouraged how to use physical
activity, dietary intake and oral medication to understand
and regulate their blood glucose levels. In the absence of
insulin treatment, these are the principle mechanisms by
which glucose control can be maintained on an hour by
hour basis for people with type 2 diabetes. This will fur-
ther test the biomedical feedback hypothesis identified as
important in the Gibson et al [13] and Norris et al [15]
systematic reviews of long-term condition management.
This trial uses self-efficacy theory throughout to train the
nurses, to promote diabetes related changes in behaviour
and as an outcome measure consisting of specific diabetes
self-management activities. Consistency of theoretical
approach will increase our understanding of the diabetes
related health behaviours that are more or less susceptible
to change through efficacy enhancing mechanisms and
how this impacts on clinical outcomes. Data relating toPage 6 of 8
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facilitators will offer valuable understanding about the
relative importance of theoretically-based nurse-patient
interaction on the clinical and psychosocial outcomes
experienced by patients.
The Ismail et al meta-analysis [10] included a number of
trials where psychological interventions were delivered by
generalist health professionals (non-mental health
trained) but did not focus on the content of the training
delivered to the nurses to enable clinically significant
reductions in HbA1c to be achieved. The current trial
offers psychological training to generalist professionals
(practice nurses) and the quality assurance procedures
will enable clinical outcome data to be compared to qual-
ity assurance data where psychological intervention fidel-
ity by the nurses was both strong and weak. This will
provide evidence on which to base further training sylla-
bus and programme development for psychological inter-
ventions.
This complex intervention, consisting of five distinct com-
ponents, has undergone development informed by the
UK Medical Research Council Framework for Develop-
ment and Evaluation of Complex Interventions [33].
Underlying theoretical principles have been developed
and tested and the forerunning Heart Manual provided
phase I data to inform the Diabetes Manual development.
The Diabetes Manual has been developed in identical
component format to the Heart Manual and demon-
strated strong face validity with both health professionals
and people with type 2 diabetes. Due to the weight of
Heart Manual evidence [22-24]. Intervention delivery
quality assurance procedures and patient interview data
will enable us to assess this transferability. With the
growth of generic chronic disease interventions interna-
tionally [17, 34, 35], the trial findings will contribute to
the debate regarding the efficacy of such approaches.
The protocol change regarding patient HbA1c eligibility
represents a trial limitation, and presenting the consort
diagram and the data interpretation will be more chal-
lenging as a result.
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